Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia

被引：0
|
作者：
Fan Yang
Li Zhang
Bei-Bei Zhao
Jing-Liao Zhang
Xi-Ting Liu
Xue Li
Bo-Hao Tang
Yue Zhou
Xin-Mei Yang
John van den Anker
Xiao-Fan Zhu
Wei Zhao
机构：
[1] Shandong University,Department of Clinical Pharmacy, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Pediatrics, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital
[3] The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital,Department of Clinical Pharmacy, Clinical Trial Center
[4] Shandong Engineering and Technology Research Center for Pediatric Drug Development,Division of Clinical Pharmacology
[5] Shandong Medicine and Health Key Laboratory of Clinical Pharmacy,Departments of Pediatrics, Pharmacology and Physiology, Genomics and Precision Medicine, School of Medicine and Health Sciences
[6] Children’s National Hospital,Department of Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel
[7] George Washington University,Department of Clinical Pharmacy, School of Pharmaceutical Sciences
[8] University of Basel,undefined
[9] Shandong University,undefined
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 81
页数：10
相关论文
共 50 条
  • [1] Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia
    Yang, Fan
    Zhang, Li
    Zhao, Bei-Bei
    Zhang, Jing-Liao
    Liu, Xi-Ting
    Li, Xue
    Tang, Bo-Hao
    Zhou, Yue
    Yang, Xin-Mei
    van den Anker, John
    Zhu, Xiao-Fan
    Zhao, Wei
    CLINICAL PHARMACOKINETICS, 2022, 61 (01) : 71 - 81
  • [2] Dasatinib in core-binding factor acute myeloid leukemia: A promising therapeutic approach
    Srinivasan, Shyam
    EJHAEM, 2024, 5 (05): : 1100 - 1101
  • [3] Core-Binding Factor Acute Myeloid Leukemia
    Sangle, Nikhil A.
    Perkins, Sherrie L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (11) : 1504 - 1509
  • [4] CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA
    Kassar, O.
    Charfi, M.
    Kallel, F.
    Ghorbel, M.
    Mdhaffar, M.
    Abdejellil, N.
    Bellaaj, H.
    Hdijji, S.
    ben Othmen, T.
    Elloumi, M.
    HAEMATOLOGICA, 2015, 100 : 375 - 375
  • [5] GENOMIC LANDSCAPE OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA
    Duployez, N.
    Marceau-Renaut, A.
    Boissel, N.
    Petit, A.
    Bucci, M.
    Geffroy, S.
    Ragu, C.
    Celli-Lebras, K.
    Lacombe, C.
    Ifrah, N.
    Dombret, H.
    Leverger, G.
    Jourdan, E.
    Lapillonne, H.
    Preudhomme, C.
    HAEMATOLOGICA, 2015, 100 : 209 - 209
  • [6] Evolving Strategies for the Management of Core-Binding Factor Acute Myeloid Leukemia
    O'Brien, Susan
    Borthakur, Gautam
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (11)
  • [7] Treatment Strategies in Patients with Core-Binding Factor Acute Myeloid Leukemia
    Solis, Erick Crespo
    CURRENT ONCOLOGY REPORTS, 2011, 13 (05) : 359 - 360
  • [8] The increasing complexity of the management of core-binding factor acute myeloid leukemia
    Litzow, Mark R.
    HAEMATOLOGICA, 2020, 105 (06) : 1475 - 1477
  • [9] Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia
    Hsiao, H. H.
    Liu, Y. C.
    Wang, H. C.
    Tsai, Y. F.
    Wu, C. H.
    Cho, S. F.
    Hsu, J. F.
    Huang, C. T.
    Hsiao, S. Y.
    Lee, C. P.
    Chang, C. S.
    Lin, S. F.
    Liu, T. C.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17028 - 17033
  • [10] Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy
    Solh, Melhem
    Yohe, Sophia
    Weisdorf, Daniel
    Ustun, Celalettin
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) : 1121 - 1131
12345